CN Patent

CN102753171A — 2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲酰胺的组合物

Assigned to Colucid Pharmaceuticals Inc · Expires 2012-10-24 · 14y expired

What this patent protects

本发明涉及公开2，4，6-三氟-N-[6-(1-甲基-哌啶-4-基羰基)-吡啶-2-基]-苯甲酰胺和药学上可接受的载体的药用组合物。

USPTO Abstract

本发明涉及公开2，4，6-三氟-N-[6-(1-甲基-哌啶-4-基羰基)-吡啶-2-基]-苯甲酰胺和药学上可接受的载体的药用组合物。

Drugs covered by this patent

lasmiditan-succinate (LASMIDITAN SUCCINATE)

Patent Metadata

Patent number: CN102753171A
Jurisdiction: CN
Classification: —
Expires: 2012-10-24
Drug substance claim: No
Drug product claim: No
Assignee: Colucid Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.